Richmond, Nov. 14, 2023 (GLOBE NEWSWIRE) -- According to a research report "Human Milk Oligosaccharides (HMO) Market, By Type (2’FL, 3’FL, 3’SL, 6’SL), By Application (Infant Formula, Functional Food & Beverage, Food Supplements), By Distribution Channel (Hypermarkets, Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, Online Sales Channel) and Region.
Global Human Milk Oligosaccharides (HMO) Market Report Scope:
| Report | Details |
| Market size value in 2022 | USD 195.6 Million |
| Market size value in 2030 | USD 928.9 Million |
| CAGR (2023-2030) | 21.5% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Type, Distribution Channel, Application and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/1073
TOC Covers in Depth & Breath on Human Milk Oligosaccharides (HMO) Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The Global Human Milk Oligosaccharides (HMO) Market plays a crucial role in the nutrition and well-being of infants. HMOs are complex carbohydrates found in human breast milk, and they provide various health benefits to new-born. These bioactive compounds serve as prebiotics, nourishing beneficial gut bacteria and promoting a healthy microbiome in infants. HMOs are also known for their ability to block the adhesion of pathogens to the intestinal lining, helping protect infants from infections and illnesses. The increased awareness of the importance of early nutrition and breastfeeding is driving the demand for HMOs in infant formula and other nutritional products. As a result, the global HMO market contributes to better infant health and nutrition outcomes, benefiting both the industry and the well-being of the youngest members of our society.
Furthermore, the global HMO market has the potential to significantly impact the infant formula and nutrition industries. As breast milk remains the gold standard for infant nutrition, infant formula manufacturers are increasingly incorporating HMOs into their products to mimic the natural benefits of breast milk. This innovation allows parents who cannot or choose not to breastfeed to provide their infants with a more comprehensive and nature-inspired nutrition source. The market also creates opportunities for the dairy industry, as some HMOs can be sourced from cow's milk. In essence, the Global HMO Market is transforming the landscape of infant nutrition, contributing to healthier beginnings for countless infants while fostering growth and innovation in the industry.
Major vendors in the global Human Milk Oligosaccharides (HMO) Market - ROYAL DSM, Biosynth Carbosynth, Dextra Laboratories Ltd, Elicityl S.A., Inbiose NV, Glycosyn, Chr. Hansen Holding A/S, Nestle Health Science, Medolac Laboratories, DuPont Nutrition & Biosciences, BASF SE, Abbott Laboratories, Royal Friesland Campina N.V, and Others.
Request for Discount @ https://www.marketdigits.com/request/discount/1073
Growing Emphasis on Infant Health and Nutrition
One of the primary drivers of the global human milk oligosaccharides (HMO) Market is the increasing emphasis on infant health and nutrition. HMOs are naturally occurring complex carbohydrates found in human breast milk. They play a pivotal role in infant health, acting as prebiotics and promoting the development of a healthy gut microbiome. As the awareness of the importance of early nutrition for infants grows, so does the demand for infant formulas and nutritional products that mimic the nutritional benefits of breast milk, particularly in regions where breastfeeding rates may be lower. Infant nutrition is a critical factor in a child's growth and development, and HMOs contribute significantly to these efforts.
HMOs offer various health benefits, including the development of a strong immune system and protection against infections. This has fueled the integration of HMOs into infant formula and other nutritional products, as parents and caregivers seek to provide the best possible nutrition for infants. The rising demand for infant formula with added HMOs is driving the growth of this market globally.
Market Dynamics
Drivers:
- Growing Emphasis on Infant Nutrition
- Increased Consumer Awareness of Health Benefits
- Expanding Application in Functional Foods
- Advancements in Biotechnology and Production Methods
Opportunities:
- Rising Demand for Clean Label and Natural Ingredients
- Expansion into Emerging Markets
- Collaborations and Partnerships in the Industry
- Innovative Product Development and Customization
Increasing Investment in Research and Development
Another major driver is the increasing investment in research and development (R&D) related to HMOs. The scientific community's understanding of the health benefits and nutritional value of HMOs is expanding. Researchers are exploring new ways to isolate, synthesize, and mass-produce HMOs to meet the growing demand for these compounds. This investment in R&D is essential for developing cost-effective methods for producing HMOs at scale, which is particularly important given the increasing global demand for these compounds in infant formula and nutritional products.
Furthermore, ongoing research is uncovering new potential applications for HMOs beyond infant nutrition. HMOs are being explored for their health benefits in areas such as adult gut health, immune support, and potentially as a functional ingredient in various food and beverage products. As R&D efforts progress, new applications and markets for HMOs may emerge, further driving the growth of the Global HMO Market.
The Market for Human Milk Oligosaccharides (HMO) is Dominated by North America.
The North American region, particularly the United States, dominates the Global HMO Market. The United States is home to several key players in the infant formula and nutrition industry, and it has a well-established market for HMO-enhanced products. The robust healthcare infrastructure, high healthcare spending, and a strong focus on infant health and nutrition contribute to the region's dominance in the HMO market. In the Asia-Pacific region, China is emerging as a significant player in the HMO market. The large population, growing middle class, and increasing consumer awareness about infant nutrition make China a key growth market for HMOs.
Furthermore, regions in Southeast Asia, such as Indonesia, Malaysia, and Vietnam, hold high growth potential. These countries have large populations and rising disposable incomes, which can drive the demand for infant nutrition products enriched with HMOs. In addition, as healthcare awareness and infrastructure improve in these regions, the market for HMOs in infant nutrition is expected to expand rapidly. Overall, the Global HMO Market is likely to observe continued growth, driven by increased understanding of their health benefits and expanded applications beyond infant nutrition.
The Infant Formula Segments is anticipated to hold the Largest Market Share during the Forecast Period
Based on application the The "Infant Formula" application segment dominates the Global Human Milk Oligosaccharides (HMO) Market due to its crucial role in infant nutrition. HMOs are naturally present in human breast milk, providing numerous health benefits to infants, including the development of a robust immune system and a healthy gut microbiome. As breastfeeding rates vary globally and many infants rely on formula feeding, there is a growing emphasis on enhancing infant formulas with HMOs to replicate the nutritional advantages of breast milk. This trend is driving the demand for HMOs in infant formula, making it the dominant application segment in the market.
To directly buy this report @ https://www.marketdigits.com/checkout/1073?lic=s
Similar Reports We Have on FMCG Industry:
Pet Milk Replacers Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Ultra High Temperature Milk Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Goat Milk Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn
